The Role of Proteostasis Derailment in Cardiac Diseases

Bianca J J M Brundel1

  • 1Department of Physiology, Amsterdam UMC, Vrije Universiteit, Amsterdam Cardiovascular Sciences, 1081 Hz Amsterdam, The Netherlands.

Cells
|October 22, 2020
PubMed

Insights

Cardiac diseases are a leading cause of death, increasing with aging populations. Protein quality control failure and disrupted protein homeostasis (proteostasis) are key factors in heart disease development.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Cardiac diseases represent a significant global health burden, with rising incidence linked to demographic shifts and lifestyle changes.
  • Understanding the molecular mechanisms underlying cardiac disease is crucial for developing effective interventions.
  • Cellular protein homeostasis (proteostasis) and protein quality control are increasingly recognized as critical determinants of cellular health.

Discussion:

  • The aging population and evolving lifestyles contribute to the growing prevalence of cardiac diseases worldwide.
  • Disruptions in cellular protein homeostasis (proteostasis) and the failure of protein quality control mechanisms are central to the pathogenesis of cardiac conditions.
  • In cardiac cells, impaired protein quality control, stemming from genetic predispositions or environmental stressors, can lead to a loss of protein integrity, initiating proteostasis collapse and disease.

Key Insights:

  • Loss of protein patency in the heart, whether due to genetic factors or environmental damage, overwhelms protein quality control systems.
  • This overwhelming of protein quality control is a critical step in the derailment of proteostasis.
  • Derailment of proteostasis directly contributes to the onset and progression of cardiac diseases.

Outlook:

  • Further research into the intricate mechanisms of proteostasis in the heart may reveal novel therapeutic targets.
  • Strategies aimed at bolstering protein quality control could offer a promising avenue for preventing or treating cardiac diseases.
  • Investigating the interplay between genetic and environmental factors in protein homeostasis disruption is essential for a comprehensive understanding of cardiac disease etiology.

Related Concept Videos

The Proteasome01:13

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important among these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
1.4K
The Proteasome02:18

The Proteasome

Eukaryotic cells can degrade proteins through several pathways. One of the most important amongst these is the ubiquitin-proteasome pathway. It helps the cell eliminate the misfolded, damaged, or unwarranted cytoplasmic proteins in a highly specific manner.
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. A series of enzymes carry out the ubiquitination of the target proteins - E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
9.7K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
2.4K
The Unfolded Protein Response01:37

The Unfolded Protein Response

The ER is the hub of protein synthesis in a cell. It has robust systems to quality control protein folding and also for degradation of terminally misfolded proteins. Under normal conditions, a small proportion of misfolded proteins that cannot be salvaged need to be transported to the cytoplasm by the ER-associated degradation or ERAD pathways. However, if the ERAD cannot handle the misfolded proteins, the cell activates the unfolded protein response or UPR to adjust the protein folding...
6.0K
Regulation of the Unfolded Protein Response01:31

Regulation of the Unfolded Protein Response

Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.8K
Export of Misfolded Proteins out of the ER01:32

Export of Misfolded Proteins out of the ER

After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
4.7K